Centrient Pharmaceuticals completes acquisition of Astral SteriTech
With the addition of Astral SteriTech's semi-synthetic cephalosporin and semi-synthetic penicillin sterile injectable finished dosage forms to Centrient's product portfolio, the company can now further meet the needs of customers and reach more patients with its critical life-saving medicine
Centrient Pharmaceuticals Completes Acquisition Of | 03/09/2021 | By Darshana | 675
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy